Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Biomodulator Patch for Subjective Tinnitus: A Randomized Controlled Trial

NCT: NCT07731230 · COMPLETED

NCT IDNCT07731230
StatusCOMPLETED
Start Date2018-06-12
Completion2021-02-27
SponsorMurat Erinç (OTHER)
First posted
Last updated

Brief Summary

This study tested whether a skin patch, worn behind the ear, could help reduce tinnitus (ringing or buzzing in the ears) in adults. Eighty participants took part. Half wore an active patch, and half wore a patch that looked the same but had no active effect (a placebo). Neither the participants nor the researchers knew who received which patch until the study ended. All participants also received an educational counseling session about tinnitus and how to manage it. Participants were assessed before treatment, three weeks later, about seven weeks later, and again about one year later. The researchers measured how much tinnitus affected their daily life, their sensitivity to sound, and their anxiety or mood.

Frequently Asked Questions

What is Biomodulator Patch for Subjective Tinnitus: A Randomized Controlled Trial?

Biomodulator Patch for Subjective Tinnitus: A Randomized Controlled Trial is a clinical trial registered under NCT07731230. Current status: COMPLETED.

What is the status of NCT07731230?

The current status of NCT07731230 (Biomodulator Patch for Subjective Tinnitus: A Randomized Controlled Trial) is: COMPLETED.

When did Biomodulator Patch for Subjective Tinnitus: A Randomized Controlled Trial start?

Biomodulator Patch for Subjective Tinnitus: A Randomized Controlled Trial started on 2018-06-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.